Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FV5DZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,064
Award facts
- Contract value 100% obligated
- $15,063.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued on August 5, 2025, is for 266 mg/20 mL vials of Exparel, a liposomal bupivacaine local anesthetic used for pain management in surgical and medical procedures. Performance is scheduled for completion by August 26, 2025, with no set-aside designation applied to this award. This delivery order was issued under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to secure recurring contracts with the Defense Logistics Agency. The company's core business involves distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare facilities. This particular delivery order for Exparel reflects the company's ongoing role in providing specialized pharmaceutical products that support military medical operations and healthcare delivery systems across the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FV5DZ?
SPE2DB25FV5DZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FV5DZ worth?
The government has obligated $15,064 on SPE2DB25FV5DZ.
Is contract SPE2DB25FV5DZ an order under another contract?
Yes. SPE2DB25FV5DZ is a delivery order under SPE2DB22D9206, an indefinite delivery contract.
Was contract SPE2DB25FV5DZ competed?
The extent of competition for SPE2DB25FV5DZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award